Advanced Search

column
Research Progress of Etiology, Screening and Early Diagnosis of Esophageal Cancer in China
YANG Huan, SUN Wanyi, WANG Jianbing, WANG Xiaokun, ZHANG Jinyu, FAN Jinhu, QIAO Youlin
2022, 49(3): 169-175. DOI: 10.3971/j.issn.1000-8578.2022.21.1033
Abstract PDF
Review of Development of Emerging Clinical Antitumor Therapeutics
ZHANG Wenqing, WU Jing, XIE Di, SHI Xuecong, HU Hankun
2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034
Abstract PDF
Inhibitory Effect of Loropetalum Chinense on Proliferation of Lung Adenocarcinoma A549 Cells
XIA Qisheng, DENG Tingting, XU Yaping, LIU Honglin, LIU Haoyuan
2022, 49(3): 182-186. DOI: 10.3971/j.issn.1000-8578.2022.21.0708
Abstract PDF
IFN-γ Inhibits Proliferation and Migration of Esophageal Squamous Cell Carcinoma by Downregulating CXCL8 Expression
CHEN Huicong, LIU Yunjiang, ZHAO Jidong, CAO Miao, LI Xinhui, REN Shuguang, ZHANG Xiangmei, SHAN Baoen
2022, 49(3): 187-191. DOI: 10.3971/j.issn.1000-8578.2022.21.0901
Abstract PDF
Effect of PTENP1 on Proliferation and Apoptosis of Colorectal Cancer Cells and Its Molecular Mechanism
HU Xiaoshu, WEN Yiyang, YANG Jinhua
2022, 49(3): 192-196. DOI: 10.3971/j.issn.1000-8578.2022.21.0819
Abstract PDF
Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma
LUO Wenqing, LI Yuanqi, YE Fei, LI Qiangming, ZHANG Guoqing, LI Xiangnan
2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623
Abstract PDF
Effects of Chemoradiotherapy Versus Chemotherapy Alone on Survival of Patients with Primary Mediastinal Large B-cell Lymphoma
FAN Bingjie, CHANG Yu, LIU Xiyang, ZHANG Mingzhi, ZHANG Lei
2022, 49(3): 205-212. DOI: 10.3971/j.issn.1000-8578.2022.21.0716
Abstract PDF
Clinical Value of Platelet and Its Parameters Combined with Tumor Markers in Preoperative Differentiation of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
ZHANG Haodong, WEI Fengxian, ZHANG Chunfang, XU Xiaodong
2022, 49(3): 213-218. DOI: 10.3971/j.issn.1000-8578.2022.21.0898
Abstract PDF
Efficacy and Safety of Apatinib Monotherapy as Subsequent-line Therapy on Patients with Advanced Esophageal Squamous Cell Carcinoma
HOU Jiyuan, QI Peihong, WANG Haixia, GONG Zhe, SHAN Guoyong
2022, 49(3): 219-224. DOI: 10.3971/j.issn.1000-8578.2022.21.0742
Abstract PDF
Research Progress of PD-L1 Expression in Circulating Tumor Cells in Malignant Tumors
LI Zuxi, HUANG Xianbin, MA Yuntao, ZHAN Weipeng, HU Ming, TIAN Hongwei, YANG Jing
2022, 49(3): 225-229. DOI: 10.3971/j.issn.1000-8578.2022.21.0648
Abstract PDF
Role and Mechanism of BDH2 Gene in Metabolism, Tumorigenesis and Progression of Cancer
LIU Bingchun, LI Kang, YUAN Jianlong
2022, 49(3): 230-234. DOI: 10.3971/j.issn.1000-8578.2022.21.0995
Abstract PDF
Advances in Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JIANG Yujuan, ZHOU Sicheng, PEI Wei, LIANG Jianwei, ZHOU Zhixiang
2022, 49(3): 235-239. DOI: 10.3971/j.issn.1000-8578.2022.21.0783
Abstract PDF
Research Progress of Exosome-based Liquid Biopsy in Diagnosis of Pancreatic Cancer
GUO Madi, ZHAO Juan, HUANG Xiaoyi
2022, 49(3): 240-245. DOI: 10.3971/j.issn.1000-8578.2022.21.1008
Abstract PDF
Diffuse Malignant Peritoneal Mesothelioma with Paraneoplastic Syndrome: A Case Report and Literature Review
SU Yandong, LIU Gang, DU Xuemei, LI Yan
2022, 49(3): 246-250. DOI: 10.3971/j.issn.1000-8578.2022.21.0445
Abstract PDF
Standardization for Diagnosis and Treatment of Primary Hepatic Carcinoma (2022 Edition)
National Health Commission of the People's Republic of China
2022, 49(3): 251-276. DOI: 10.3971/j.issn.1000-8578.2022.03.0001
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：